Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 5,265 | 3,275 | 3,197 | 2,537 | 2,132 |
| Operating Income | -5,265 | -3,275 | -3,197 | -2,537 | -2,132 |
| Other Income | 2 | 2 | 2 | 0 | 0 |
| Pre-tax Income | -5,263 | -3,273 | -3,195 | -2,537 | -2,132 |
| Net Income Continuous | -5,263 | -3,273 | -3,195 | -2,537 | -2,132 |
| Minority Interests | -2 | N/A | N/A | 1 | -23 |
| Net Income | $-5,261 | $-3,273 | $-3,195 | $-2,538 | $-2,109 |
| EPS Basic Total Ops | -2.75 | -6.25 | -6.00 | -32.50 | -35.00 |
| EPS Basic Continuous Ops | -10.04 | -6.20 | -6.05 | -6.98 | -22.93 |
| EPS Diluted Total Ops | -2.75 | -6.25 | -6.00 | -32.50 | -35.00 |
| EPS Diluted Continuous Ops | -10.04 | -6.20 | -6.05 | -6.98 | -22.93 |
| EBITDA(a) | $-5,252 | $-3,257 | $-3,174 | $-2,504 | $-2,100 |